 Date: 2016-08-05 15:09:42Endocrine system Androgens Andrology Medicine RTT Male genital disorders Testosterone Androgen replacement therapy Hypogonadism TAP Pharmaceuticals Food and Drug Administration Prostate cancer | |  Aytu BioScience Corporate Overview | August 2016 Safe Harbor Statement This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E o
Add to Reading ListSource URL: aytubio.comDownload Document from Source Website File Size: 1,31 MBShare Document on Facebook
|
